New York, NY -- (ReleaseWire) -- 02/08/2013 -- Growing Stock Report adds Tranzyme, Inc. (NASDAQ:TZYM) and 3SBio Inc. (NASDAQ:SSRX) to their NASDAQ Gainers Watch List.
Tranzyme, Inc. (NASDAQ:TZYM) a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of acute and chronic gastrointestinal (GI) motility disorders in the United States and internationally is up (+TZYM) on 3,003,042 shares traded as TZYM announced today that its Board of Directors has made a determination to explore and evaluate strategic alternatives, including the possibility of a merger, sale, other form of business combination, or other transaction to maximize value to its stockholders. With this announcement and the current price increase in shares, Growing Stock Report adds Tranzyme, Inc. (NASDAQ:TZYM) to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Tranzyme, Inc.
3SBio Inc. (NASDAQ:SSRX) a biotechnology company, engages in the research and development, manufacture, and distribution of pharmaceutical products in the People’s Republic of China is currently up (+7.07%) with a surprising volume of 1,117,242 which is 15 times more over their average daily volume after 3SBio announced today that they will go private in $340 million deal. With this news and price pencentage increase Growing Stock Report adds 3SBio Inc. (NASDAQ:SSRX) to their NASDAQ Gainers Watch List.
Click Here to see what other investors are saying about 3SBio Inc.
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report